Drugs News and Research

RSS

Sulfasalazine drug does not reduce diarrhea for patients receiving pelvic radiation therapy: Study

Sulfasalazine, a drug commonly prescribed to reduce diarrhea in patients with inflammatory bowel disease, does not reduce diarrhea in patients receiving radiation therapy for cancers in the pelvic area a Mayo Clinic-led study has found.

24 Sep 2013

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Boehringer Ingelheim and Eli Lilly and Company today announced results from two post-hoc, pooled analyses of data from placebo-controlled clinical trials, which examined the safety of the dipeptidyl peptidase-4 inhibitor linagliptin in adults with type 2 diabetes.

24 Sep 2013

Messages that warn consumers about potentially harmful side effects increase product sales

Drug ads often warn of serious side effects, from nausea and bleeding to blindness, even death. New research suggests that, rather than scaring consumers away, these warnings can improve consumers' opinions and increase product sales when there is a delay between seeing the ad and deciding to buy or consume the product.

24 Sep 2013

JPM, Bill & Melinda Gates Foundation announces capital raise for first-of-its-kind investment product

A new investment fund structured by JPMorgan Chase & Co. (NYSE: JPM) and the Bill & Melinda Gates Foundation will, for the first time, allow individual and institutional investors the opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries.

24 Sep 2013

Frequency of marijuana use not linked to health services utilization or health status

Researchers from Boston Medical Center and Boston University School of Medicine have found frequency of marijuana use was not significantly associated with health services utilization or health status. These findings currently appear online in the Journal of General Internal Medicine.

24 Sep 2013

Alefacept drug shows encouraging results in phase 2 trial for type 1 diabetes

A drug formerly used to treat the skin disorder psoriasis has shown encouraging results in a phase 2 trial to assess its effectiveness in treating type 1 diabetes, according to new research published in The Lancet Diabetes & Endocrinology.

24 Sep 2013

Viewpoints: GOP opponents to health care listening 'only to their own choir,' Congress should turn down federal contribution for insurance

Yes, a majority doesn't like Obamacare. They're unsure about what it will do and worried that it might make their health care worse. But do they really want to defund the law, and risk the chaos of a government shutdown to do it? Probably not, most polls suggest. As one Republican pollster told me, though a majority of voters don't like Obamacare, they're not angry enough about it to risk a fiscal crisis that could hurt the economy. So why are Republican lawmakers hearing a different message? Because most of them represent districts so conservative that they are listening only to their own choir (Doyle McManus, 9/22).

24 Sep 2013

Long-term abstinence from cocaine does not result in complete normalization of brain circuitry

It is often said that once people develop an addiction, they can never completely eliminate their attraction to the abused substance. New findings provide further support for this notion by suggesting that even long-term abstinence from cocaine does not result in a complete normalization of brain circuitry.

24 Sep 2013

Pretravel consultations, malaria preventive medications save money for travelers to West Africa

Not only do U.S. travelers to West Africa who consult health providers before they leave and take prescribed preventive medications substantially reduce their risk of contracting malaria, they also reduce costs to their health insurance providers and, in most cases, to themselves.

24 Sep 2013

ACR journals publish guide that provides new treatments for children with systemic JIA

In the U.S., there are nearly 300,000 children with juvenile arthritis and other rheumatic illnesses according to estimates from the American College of Rheumatology (ACR). For pediatric patients with systemic juvenile idiopathic arthritis (JIA), effective treatment for this disabling disease is imperative.

24 Sep 2013

Study suggests certain pediatric surgeries carry low risk of serious blood loss

Certain pediatric surgeries carry such low risk of serious blood loss that clinicians can safely forgo expensive blood typing and blood stocking before such procedures, suggest the results of a small study by researchers at the Johns Hopkins Children's Center.

24 Sep 2013

FDA approves revised labeling for Sapien Transcatheter Heart Valve

The U.S. Food and Drug Administration today approved revised labeling for the Sapien Transcatheter Heart Valve, making the device available to an expanded group of patients who have inoperable aortic valve stenosis, a disease of the heart valves that causes narrowing of the aortic valve, restricting blood flow from the heart.

24 Sep 2013

Researchers develop first imaging tool to examine myelin damage in MS

Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.

24 Sep 2013

Study: Ciclopirox drug completely eradicates infectious HIV from cell cultures

The topical anti-fungal drug Ciclopirox causes HIV-infected cells to commit suicide by jamming up the cells' powerhouse, the mitochondria—according to a study by researchers at Rutgers New Jersey Medical School. And unlike current anti-HIV drugs, Ciclopirox completely eradicates infectious HIV from cell cultures, with no rebound of virus when the drug is stopped.

24 Sep 2013

FDA's final guidance outlines tailored approach to mobile medical apps

Today, the U.S. Food and Drug Administration issued final guidance for developers of mobile medical applications, or apps, which are software programs that run on mobile communication devices and perform the same functions as traditional medical devices. The guidance outlines the FDA's tailored approach to mobile apps.

24 Sep 2013

Researchers reveals key role for stem cells that promote inflammation in atherosclerosis

University at Buffalo translational researchers are developing a richer understanding of atherosclerosis in humans, revealing a key role for stem cells that promote inflammation.

24 Sep 2013

Abbvie, Ablynx Ink Up To $840M RA, SLE Collaboration

...

23 Sep 2013

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) alone or in combination with methotrexate for the treatment of adult patients (18 years or older) with active psoriatic arthritis.

23 Sep 2013

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

Lpath, Inc., the industry leader in lipidomics-based therapeutics, announced receipt of a Notice of Grant Award from the National Institutes of Health (NIH). This $145,000 Phase 1 SBIR grant will support the study of Lpath's therapeutic monoclonal antibody, Lpathomab™, in animal models of diabetic neuropathic pain and diabetic neuropathy.

23 Sep 2013

Odour of newborns activates neural reward circuit in mothers, elicits maternal care functions

What woman has not wanted to gobble up a baby placed in her arms, even if the baby is not hers? This reaction, which everyone has noticed or felt, could have biological underpinnings related to maternal functions.

23 Sep 2013

Drugs News and Research

Sulfasalazine drug does not reduce diarrhea for patients receiving pelvic radiation therapy: Study

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Messages that warn consumers about potentially harmful side effects increase product sales

JPM, Bill & Melinda Gates Foundation announces capital raise for first-of-its-kind investment product

Frequency of marijuana use not linked to health services utilization or health status

Alefacept drug shows encouraging results in phase 2 trial for type 1 diabetes

Viewpoints: GOP opponents to health care listening 'only to their own choir,' Congress should turn down federal contribution for insurance

Long-term abstinence from cocaine does not result in complete normalization of brain circuitry

Pretravel consultations, malaria preventive medications save money for travelers to West Africa

ACR journals publish guide that provides new treatments for children with systemic JIA

Study suggests certain pediatric surgeries carry low risk of serious blood loss

FDA approves revised labeling for Sapien Transcatheter Heart Valve

Researchers develop first imaging tool to examine myelin damage in MS

Study: Ciclopirox drug completely eradicates infectious HIV from cell cultures

FDA's final guidance outlines tailored approach to mobile medical apps

Researchers reveals key role for stem cells that promote inflammation in atherosclerosis

Abbvie, Ablynx Ink Up To $840M RA, SLE Collaboration

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

Odour of newborns activates neural reward circuit in mothers, elicits maternal care functions

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News